Kymera
building franchises in immunology and oncology in diseases with large unmet needs and commercial opportunities | Kymera
Company
Deck Type
Sector
Industry
Deck date
August 2023
Slide
6 of 60
Similar slides by Kymera
See diffirences between slides (animation)
Investor Presentation
June 2023
building franchises in immunology and oncology in diseases with large unmet needs and commercial opportunities | Kymera
Related slides by other companies
Alkermes
Investor Day
March 2021
agents that induce immunogenic cell death may offer synergistic advantages in combination with combination with growth factor pathway inhibitors chemotherapy or radiation immune inhibitors anti ongoing clinical trials anti growth factor pathway inhibitors tyrosine kinase inhibitors anti antibodies cytotoxic chemotherapies radiation activated cancer fighting cells pharmacotherapy alkermes | Alkermes
Other recent decks by Kymera
See all presentations (7 decks)
Investor Presentation
December 2023
Investor Presentation
November 2023
Investor Presentation
June 2023
Results
December 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights